Browse > Article
http://dx.doi.org/10.4062/biomolther.2015.035

The Pharmacological Effects of Benachio-F® on Rat Gastrointestinal Functions  

Poudel, Bijay Kumar (College of Pharmacy, Yeungnam University)
Yu, Jae Young (Dong-A Pharmaceutical Co. Ltd.)
Kwon, Yong Sam (Dong-A Pharmaceutical Co. Ltd.)
Park, Hyoung Geun (Dong-A Pharmaceutical Co. Ltd.)
Son, Miwon (Dong-A Pharmaceutical Co. Ltd.)
Jun, Joon Ho (Dong-A Pharmaceutical Co. Ltd.)
Kim, Jeong Ah (College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University)
Kim, Jong Oh (College of Pharmacy, Yeungnam University)
Publication Information
Biomolecules & Therapeutics / v.23, no.4, 2015 , pp. 350-356 More about this Journal
Abstract
Functional dyspepsia (FD) is a prevalent idiopathic upper gastrointestinal (GI) disorder characterized by diverse symptomatology including epigastric pain or discomfort, postprandial fullness, and early satiety. Although its pathophysiological mechanisms have not yet been fully established, the available studies suggest that the etiology of FD is invariably multifactorial. Benachio-F$^{(R)}$ (BF) is a proprietary liquid formulation of 7 herbal extracts that has been proposed to address this multifactorial etiology using multi-drug phytotherapy. The pharmacological effects of BF, in comparison with those of two other herbal products (Whalmyungsu$^{(R)}$; WM and Iberogast$^{(R)}$; IB) were evaluated in rats. In a laparotomy-induced rat model of delayed GI transit, BF significantly accelerated the delayed gastric emptying caused by morphine, apomorphine, and cisplatin, and also significantly increased mean gastric transit, as compared to the control animals. BF markedly increased gastric accommodation in rats and produced higher gastric volume values than did the control treatment. The effects of BF were generally comparable or superior to those of WM and IB in these models. Furthermore, BF significantly stimulated biliary flow, as compared to the control treatment. These results indicated that BF might have great potential as an effective phytotherapeutic agent capable of reducing GI symptoms and increasing quality of life in FD patients.
Keywords
Functional dyspepsia; Benachio-F$^{(R)}$; Gastric emptying; Gastric accommodation; Gastric transit; Bile secretion;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Allescher, H. D. (2006) Functional dyspepsia-a multicausal disease and its therapy. Phytomedicine 13, 2-11.   DOI   ScienceOn
2 Ammon, H. P., Kelber, O. and Okpanyi, S. N. (2006) Spasmolytic and tonic effect of lberogast (STWS) in intestinal smooth muscle. Phytomedicine 13, 67-74.
3 Aro, P., Talley, N. J., Agreus, L. and Johansson, S. E., Bolling-Sternevald, E., Storskrubb, T., Ronkainen, J. (2011) Functional dyspepsia impairs quality of life in the adult population. Aliment. Pharmacol. Ther. 33, 1215-1224.   DOI
4 Blancquaert, J. P., Lefebvre, R. A. and Willems, J. L. (1982) Gastric relaxation by intravenous and intracerebroventricular administration of apomorphine, morphine and fentanyl in the conscious dog. Arch. Int. Pharmacodyn. Ther. 256, 153-154.
5 Camilleri, M., Dubois, D., Coulie, B., Jones, M., Kahrilas, P. J., Rentz, A. M., Sonnenberg, A., Stanghellini, V., Stewart, W. F., Tack, J., Talley, N. J., Whitehead, W. and Revicki, D. A. (2005) Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin. Gastroenterol. Hepatol. 3, 543-552.   DOI
6 Chang L. (2004) Epidemiology and quality of life in functional gastrointestinal disorders. Aliment. Pharmacol. Ther. 20, 31-39.
7 Chopra, R. N., Nayar, S. L. and Chopra, I. C. (1956) Glossary of Indian Medicinal Plants. Council of Scientific and Industrial Research, New Delhi.
8 De Winter, B. Y., Boeckxstaens, G. E., De Man, J. G., Moreels, T. G., Herman, A. G. and Pelckmans, P. A. (1998) Differential effect of indomethacin and ketorolac on postoperative ileus in rats. Eur. J. Pharmacol. 344, 71-76.   DOI
9 Halder, S. L., and Talley, N. J. (2007) Functional dyspepsia: a new rome III paradigm. Curr. Treat. Options Gastroenterol. 10, 259-272.   DOI
10 Heinle, H., Hagelauer, D., Pascht, U., Kelber, O. and Weiser, D. (2006) Intestinal spasmolytic effects of STW 5 (Iberogast) and its components. Phytomedicine 13, 75-79.   DOI
11 Hofmann, A. F. (1999) The continuing importance of bile acids in liver and intestinal disease. Arch. Intern. Med. 159, 2647-2658.   DOI
12 Holte, K. and Kehlet, H. (2000) Postoperative ileus: a preventable event. Br. J. Sur. 87, 1480-1493.   DOI
13 Holtmann, G, Talley, N. J., Liebregts, T., Adam, B. and Parow, C. (2006) A placebo-controlled trial of itopride in functional dyspepsia. N. Engl. J. Med. 354, 832-840.   DOI
14 Kalff, J. C., Buchholz, B. M., Eskandari, M. K., Hierholzer, C., Schraut, W. H., Simmons, R. L. and Bauer, A. J. (1999) Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 126, 498-509.   DOI
15 Kimura, Y. and Sumiyoshi, M. (2012) Effects of an Atractylodes lancea rhizome extract and a volatile component ${\beta}$-eudesmol on gastrointestinal motility in mice. J Ethnopharmacol. 141, 530-536.   DOI
16 Klein, S., Rister, R. and Riggins, C. (1998) The complete German commission E monographs: therapeutic guide to herbal medicines, American Botanical Council, Austin.
17 Koo, J., Lee, S., Seo, B. (2010) A philological study on poisoning of herbal medicines used to activate blood flow and remove blood stasis. Kor. J. Herbology. 25, 21-39.
18 Loizzo, A., De Carolis, A. S. and Longo, V. G. (1971) Studies on the central effects of bulbocapnine. Psychopharmacologia 22, 234-249.   DOI
19 Kreiss, C., Birder, L. A., Kiss, S., VanBibber, M. M. and Bauer, A .J. (2003) COX-2 dependent inflammation increases spinal Fos expression during rodent postoperative ileus. Gut 52, 527-534.   DOI
20 Lee, T. H., Choi, J. J., Kim, D. H., Choi, S., Lee, K. R., Son, M. and Jin, M. (2008) Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber. Phytomedicine 15, 836-843.   DOI   ScienceOn
21 Lyu, J. H. and Lee, H. T. (2013) Effects of dried Citrus unshiu peels on gastrointestinal motility in rodents. Arch. Pharm. Res. 36, 641-648.   DOI   ScienceOn
22 Ma, W. G., Fukushi, Y., Tahara, S. and Osawa, T. (2000) Fungitoxic alkaloids from Hokkaido Papaveraceae. Fitoterapia 71, 527-534.   DOI
23 Madisch, A., Holtmann, G., Mayr, G., Vinson, B. and Hotz, J. (2004) Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial. Digestion 69, 45-52.   DOI
24 Mizuta, Y., Shikuwa, S., Isomoto, H., Mishima, R., Akazawa, Y., Masuda, J., Omagari, K., Takeshima, F. and Kohno, S. (2006) Recent insights into digestive motility in functional dyspepsia. J. Gastroenterol. 41, 1025-1040.   DOI
25 Ozaki, A. and Sukamoto, T. (1999) Improvement of cisplatin induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist. Gen. Pharmacol. 33, 283-288.   DOI
26 Raveendra, K. R., Jayachandra., Srinivasa, V., Sushma, K. R., Allan, J. J., Goudar, K. S., Shivaprasad, H. N., Venkateshwarlu, K., Geetharani, P., Sushma, G. and Agarwal, A. (2012) An extract of glycyrrhiza glabra (GutGard) alleviates symptoms of functional dyspepsia: a randomized, double-blind, placebo-controlled study. Evid. Based Complement. Alternat. Med. 2012, 216970.
27 Piessevaux, H., De Winter, B., Louis, E., Muls, V., De Looze, D., Pelckmans, P., Deltenre, M., Urbain, D. and Tack, J. (2009) Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol. Motil. 21, 378-388.   DOI
28 Pilichiewicz, A. N., Horowitz, M., Russo, A., Maddox, A. F., Jones, K. L., Schemann, M., Holtmann, G. and Feinle-Bisset, C. (2006) Effects of Iberogasts on proximal gastric volume, antropyloroduodenal (APD) motility and gastric emptying in healthy men. Am. J. Gastroenterol. 102, 1276-1283.
29 Rao, C. V., Vijayakumar, M., Sairam, K. and Kumar, V. (2008) Antidiarrhoeal activity of the standardised extract of Cinnamomum tamala in experimental rats. J. Nat. Med. 62, 396-402.   DOI
30 Robles, B. J., Sandoval, A. R., Dardon, J. D. and Blas, C. A. (2013) Lethal liquorice lollies (liquorice abuse causing pseudohyperaldosteronism) BMJ Case Rep. (doi: 10.1136/bcr-2013-201007)   DOI
31 Rosch, W., Liebregts, T., Gundermann, K.J., Vinson B. and Holtmann, G. (2006) Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 13, 114-121.   DOI
32 Schemann, M., Michel, K., Hohenester, B. and Ruhl A. (2006) Regionspecific effects of STW 5 and its components in gastric fundus, corpus and antrum. Phytomedicine 13, 90-99.   DOI
33 Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J. R. and Stanghellini, V. (2006) Functional gastroduodenal disorders. Gastroenterology 130, 1466-1479.   DOI
34 Sharma, S. S. and Gupta, Y. K. (1998) Reversal of cisplatin-induced delay in gastric emptying in rats by ginger (Zingiber offi cinale). J. Ethnopharmacol. 62, 49-55.   DOI
35 Stanghellini, V., De Ponti, F., De Giorgio, R., Barbara, G., Tosetti, C. and Corinaldesi, R. (2003) New developments in the treatment of functional dyspepsia. Drugs 63, 869-892.   DOI
36 Suzuki, H., Nishizawa, T. and Hibi, T. (2006) Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classifi cation. J. Gastroenterol. 41, 513-523.   DOI
37 Thompson, C. J. and Ernst, E. (2002) Systematic review: herbal medicinal products for non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 16, 1689-1699.   DOI
38 Thompson, W. G. (2006) The road to Rome. Gastroenterology 130, 1552-1556.   DOI
39 Tougas, G., Eaker, E. Y., Abell, T. L., Abrahamsson, H., Boivin, M., Chen, J., Hocking, M. P., Quigley, E. M., Koch, K. L., Tokayer, A. Z., Stanghellini. V., Chen, Y., Huizinga, J. D., Ryden, J., Bourgeois, I. and McCallum, R. W. (2000) Assessment of gastric emptying using a low fat meal: establishment of international control values. Am. J. Gastroenterol. 95, 1456-1462.   DOI
40 Tyers, M. B. (1991) 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists. Therapie (Paris) 46, 431-435.
41 Wagner H. (2006) Multitarget therapy-the future of treatment for more than just functional dyspepsia. Phytomedicine 13 Suppl 5,122-129.   DOI
42 Yoshida, N., Omoya, H., Oka, M., Furukawa, K., Ito, T. and Karasawa, T. (1989) AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch. Int. Pharmacodyn. Ther. 300, 51-67.
43 Wegenera, T. and Wagnerb, H. (2006) The active components and the pharmacological multi-target principle of STW 5 (Iberogasts). Phytomedicine 13, 20-35   DOI
44 Wysowski, D. K., Corken, A., Gallo-Torres, H., Talarico, L. and Rodriguez, E. M. (2001) Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. Am. J. Gastroenterol. 96, 1698-1703.   DOI
45 Yamahara, J., Huang, Q., Li, Y., Xu, L. and Fujimura, H. (1990) Gastrointestinal motility enhancing effect of ginger and its constituents. Chem. Pharm. Bull. 38, 430-431.   DOI
46 Zittel, T. T., Meile, T., Jehle, E. C. and Becker, H. D. (2001) Intraperitoneal capsaicin treatment reduces postoperative gastric ileus in awake rats. Langenbecks Arch. Surg. 386, 204-211.   DOI